Clinical Outcomes of everolimus-eluting Bioresorbable vascular scaffolds (BVS) in patients with coronary artery disease underwent percutaneous coronary intervention in a real world setting
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 24 Nov 2016 New trial record